Cargando…
In vivo efficiency of the produced recombinant lysostaphin antimicrobial peptide in treatment of methicillin-resistant Staphylococcus aureus (MRSA) skin infection in a mouse model
BACKGROUND AND OBJECTIVES: Staphylococcus simulans secretes an antimicrobial compound called lysostaphin, which has bactericidal properties. It destroys staphylococci through the hydrolysis of peptidoglycan in the cell wall. Therefore, this unique property indicates the high ability of lysostaphin i...
Autores principales: | Sadoogh Abbasian, Shabnam, Ghaznavi-Rad, Ehsanollah, Sadelaji, Samira, Abtahi, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183077/ https://www.ncbi.nlm.nih.gov/pubmed/37193239 http://dx.doi.org/10.18502/ijm.v15i2.12476 |
Ejemplares similares
-
Cloning, Expression, and Purification of Recombinant Lysostaphin From Staphylococcus simulans
por: Farhangnia, Leila, et al.
Publicado: (2014) -
In Vitro and in Vivo Antistaphylococcal Activity Determination of the New Recombinant Lysostaphin Protein
por: Abtahi, Hamid, et al.
Publicado: (2016) -
Overexpression and Enzymatic Assessment of Antigenic Fragments of Hyaluronidase Recombinant Protein From Streptococcus pyogenes
por: Sadoogh Abbasian, Shabnam, et al.
Publicado: (2014) -
Recombinant Lysostaphin Protects Mice from Methicillin-Resistant Staphylococcus aureus Pneumonia
por: Chen, Chen, et al.
Publicado: (2014) -
Thermally triggered release of the bacteriophage endolysin CHAP(K) and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)
por: Hathaway, Hollie, et al.
Publicado: (2017)